Back to RGEN
PRICE T ROWE ASSOCIATES INC /MD/ → RGEN
PRICE T ROWE ASSOCIATES INC /MD/ RGEN Position History
Repligen Corporation • Healthcare
Quarters held
12
Latest value
$1.5M
Q3 2026
Peak value
$745.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $745.2M |
| Q4 2025 | $8.4M |
| Q4 2025 | $1.1M |
| Q1 2026 | $6.6M |
| Q1 2026 | $568.1M |
| Q1 2026 | $1.3M |
| Q2 2026 | $230.7M |
| Q2 2026 | $8.4M |
| Q2 2026 | $1.9M |
| Q3 2026 | $378.3M |
| Q3 2026 | $12M |
| Q3 2026 | $1.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.5M | 95.3K | — | — |
| Q3 2026 | $12M | 62.5K | — | — |
| Q3 2026 | $378.3M | 1.97M | — | — |
| Q2 2026 | $1.9M | 88.8K | — | — |
| Q2 2026 | $8.4M | 61.4K | — | — |
| Q2 2026 | $230.7M | 1.69M | — | — |
| Q1 2026 | $1.3M | 72.6K | — | — |
| Q1 2026 | $568.1M | 4.82M | — | — |
| Q1 2026 | $6.6M | 56.3K | — | — |
| Q4 2025 | $1.1M | 60.0K | — | — |
| Q4 2025 | $8.4M | 51.1K | — | — |
| Q4 2025 | $745.2M | 4.55M | — | — |
Other funds holding RGEN
$1.1B
$752.2M
$680.3M
$635.3M
$622.5M
$620.8M
$596.6M
$568.2M